Researchers Submit Patent Application, “Dna Medicated Collection Kits”, for Approval
By a
The patent's assignee is
News editors obtained the following quote from the background information supplied by the inventors: "With the changing reimbursements, types of health care insurance, and new regulations with regards to treatment, a medical practitioner and his/her team when treating a patient is under immense time pressures to perform quickly, efficiently and with safety for the patient. The medical practitioner can lose valuable time trying to not only locate the necessary drugs and materials to treat the patient but as well to insure the compliance, the safety of the patient by preventing contamination. In some instances, not all the drugs and materials may be readily available, in the current exam room, resulting in delayed treatment and possible and potential medical errors. In addition, the medical practitioner or his/her team may make a mistake by incorrectly choosing the drug, by incorrectly identifying the product, not checking the expiration date, not returning it to the proper environment for storage, or not having enough product. Additionally, a DNA analysis by itself is limited in the kind of information that it can provide about a patient.
"There is a need in the art for a convenience kit that solves the above mentioned problems particularly in the field of DNA collection from patients and can provide additional information about a patient not possible solely with a DNA analysis."
As a supplement to the background information on this patent application, NewsRx correspondents also obtained the inventor's summary information for this patent application: "Provided is a kit comprising a first container and following components placed inside the first container: a) a second container for collection of a urine sample; and b) a tool for collection of cells for DNA (Deoxyribonucleic acid) testing from a person's buccal area. The tool can be one or more buccal swabsticks. The kit can further comprise a local anesthetic. The local anesthetic can be lidocaine hydrochloride. The kit can further comprise one or more components for cleaning the buccal area. The one or more components for cleaning the buccal area can be selected from the group consisting of one or more of mouthwash, floss, to toothbrush, and combinations thereof. The kit can further comprise a soothing agent. The soothing agent can be glycerin in form of a glycerin swab. The first container can be a box with a lid. The kit can further comprise one or more of gloves, face mask and CSR (
"Provided is a kit comprising a first container and following components placed therein: a) a first tool for collection of cells for DNA (Deoxyribonucleic acid) testing from a person's buccal area; b) a local anesthetic; and c) a soothing agent. The first tool can be one or more buccal swabsticks. The local anesthetic can be lidocaine hydrochloride. The soothing agent can be one or more of glycerin swabs. The kit can further comprise one or more items for cleaning the buccal area. The one or more components for cleaning the buccal area can be selected from the group consisting of one or more of mouthwash, floss, toothbrush, and combinations thereof. The kit can comprise one or more of gloves, face mask and CSR (
"Provided is a kit comprising a) one or more components for collecting a sample (such as cells) for DNA analysis from buccal (cheek/mouth) area of a person; b) one or more components for collecting a patient's urine. The DNA can be collected with buccal swabsticks. The urine can be collected with a container such as a urine cup. The kit can further comprise one or more of lidocaine hydrochloride oral topical solution, mouthwash, gloves, face mask and CSR wrap. The urine can be used to test for presence of any active pharmaceutical ingredient (or metabolite) such as those that are listed below, including clopidogrel. The sample can be tested for genes that regulate one or more of P450 CYP2C19, CYP2C9 and CYP2D6 activity. The dose of the drug can subsequently be adjusted according to how a patient metabolizes a drug and the genes that the person has. The kit can also be used to take a DNA sample for testing to determine a Genetic Addiction Risk Score (GARS) and a sample of urine for presence and/or amount of one or more of active pharmaceutical ingredient (or metabolite).
"Provided is a kit comprising a holder (typically a box) and following components placed inside the holder: a) a container of lidocaine HCl suitable for oral topical administration; b) mouthwash; c) toothbrush or floss string; d) swabsticks; e) oral glycerin swabs; f) gloves; g) face mask; and h) CSR wrap.
"Each component of the kit can be placed in an individual package or a third container. Typically the mask does not have a wrapping.
BRIEF DESCRIPTION OF THE FIGURES
"FIG. 1 illustrates a box for holding components of the kit.
"FIG. 2 illustrates a glove.
"FIG. 3 illustrates a face mask.
"FIG. 4 illustrates an instruction sheet.
"FIG. 5 illustrates a CSR wrap.
"FIG. 6 illustrates a swabstick and packaging for such swabstick.
"FIG. 7 illustrates a urine cup or container.
"FIG. 8 illustrates a toothbrush.
"FIG. 9 illustrates a bottle.
"FIG. 10 illustrates a sealed cap with a swab having a DNA sample. The stick is discarded.
"FIG. 11 illustrates a piece of floss"
For additional information on this patent application, see: Nickell,
Keywords for this news article include: Anesthetics,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2015, NewsRx LLC
Advisor News
- The best way to use a tax refund? Create a holistic plan
- CFP Board appoints K. Dane Snowden as CEO
- TIAA unveils ‘policy roadmap’ to boost retirement readiness
- 2026 may bring higher volatility, slower GDP growth, experts say
- Why affluent clients underuse advisor services and how to close the gap
More Advisor NewsAnnuity News
- Annuities: A key tool in battling inflation
- Pinnacle Financial Services Launches New Agent Website, Elevating the Digital Experience for Independent Agents Nationwide
- Insurer Offers First Fixed Indexed Annuity with Bitcoin
- Assured Guaranty Enters Annuity Reinsurance Market
- Ameritas: FINRA settlement precludes new lawsuit over annuity sales
More Annuity NewsHealth/Employee Benefits News
- Farmers now owe a lot more for health insurance
- On the hook for uninsured, counties weighing costs
- Research from Northwestern University Feinberg School of Medicine Yields New Findings on Managed Care (Systematic Review of Managed Care Medicaid Outcomes Versus Fee-for-Service Medicaid Outcomes for Youth in Foster Care): Managed Care
- Researchers from University of Alabama Report Details of New Studies and Findings in the Area of Managed Care (Nursing leadership in Housing First implementation: A comparative analysis of care coordination approaches across four U.S. states): Managed Care
- Studies from Johns Hopkins University Bloomberg School of Public Health in the Area of Mental Health Diseases and Conditions Described (Mental health care use after leaving Medicare Advantage for traditional Medicare): Mental Health Diseases and Conditions
More Health/Employee Benefits NewsLife Insurance News